| Liu, Yi |
NCT05250050: Susceptibility-Guided Therapy for Helicobacter Pylori Infection Treatment |
|
|
| Recruiting | 4 | 388 | RoW | Esomeprazole, Bismuth potassium citrate, Metronidazole, Clarithromycin, Levofloxacin, Amoxicillin, Tetracycline | Shanghai Zhongshan Hospital | Helicobacter Pylori Infection | 12/22 | 03/23 | | |
NCT05438875: The Combination of ATRA and Eltrombopag as the Treatment of Steroid-resistant/Relapse ITP Based on MSC-C5b-9 |
|
|
| Recruiting | 3 | 96 | RoW | all-trans retinoic acid, retinoic acid, Eltrombopag, TPO-RA | Peking University People's Hospital, Beijing Friendship Hospital, Beijing Tongren Hospital, Beijing Hospital, Navy General Hospital, Beijing | Purpura, Thrombocytopenic, Idiopathic | 12/24 | 03/25 | | |
NCT06601283: Vitamin C Plus Herbal Medicine to Chemotherapy Related Anemia in Pancreatic Cancer |
|
|
| Not yet recruiting | 2/3 | 50 | RoW | Vitmain C plus herbal medicine | Fudan University | Pancreatic Cancer | 10/26 | 10/27 | | |
BLISSc-ILD, NCT05878717: A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease |
|
|
| Recruiting | 2/3 | 300 | Europe, Japan, US, RoW | Belimumab, BENLYSTA™, GSK1550188, LymphoStat-B™, BENLYSTATM, GSK1550188, LymphoStat-B™, Placebo | GlaxoSmithKline | Systemic Sclerosis Associated Interstitial Lung Disease, Scleroderma, Systemic | 07/27 | 07/27 | | |
|
NCT05212051: Evaluate the Preliminary Efficacy, Safety, and PK of Subcutaneous JS005 in Chinese Adult Patients With Active AS |
|
|
| Recruiting | 2 | 120 | RoW | JS005, Recombinant humanized anti-IL-17A monoclonal antibody injection, Placebo | Shanghai Junshi Bioscience Co., Ltd., Sponsor GmbH | Active Ankylosing Spondylitis | 11/22 | 01/23 | | |
NCT04324879: A Study of TQ-B3525 in the Treatment of Relapsed / Refractory Follicular Lymphoma (FL) |
|
|
| Recruiting | 2 | 80 | RoW | TQ-B3525 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Relapsed / Refractory Follicular Lymphoma | 12/22 | 12/22 | | |
NCT05242588: Evaluate the Preliminary Efficacy, Safety, and PK of Subcutaneous JS005 in Chinese Adult Patients With Active Nr-axSpA |
|
|
| Recruiting | 2 | 120 | RoW | JS005, Recombinant humanized anti-IL-17A monoclonal antibody injection, Placebo | Shanghai Junshi Bioscience Co., Ltd., Sponsor GmbH | Non-radiographic Axial Spondyloarthritis | 04/23 | 06/23 | | |
NCT06176235: Teriflunomide Plus High-dose Dexamethasone as First-line Treatment in Newly Diagnosed Primary Immune Thrombocytopenia |
|
|
| Recruiting | 2 | 132 | RoW | Teriflunomide, AUBAGIO, Dexamethasone | Peking University People's Hospital, Beijing Luhe Hospital, Chinese PLA General Hospital, Navy General Hospital, Beijing, Beijing Hospital, Beijing Friendship Hospital, Peking University First Hospital, Peking University Third Hospital, China-Japan Friendship Hospital, Beijing Tsinghua Changgeng Hospital | Immune Thrombocytopenia | 12/24 | 05/25 | | |
NCT05932524: Low-dose Baricitinib Plus High-dose Dexamethasone for Patients With Newly Diagnosed Immune Thrombocytopenia |
|
|
| Recruiting | 2 | 132 | RoW | Baricitinib 2 MG, Olumiant, Dexamethasone, HD-DXM | Peking University People's Hospital, Beijing Luhe Hospital, Chinese PLA General Hospital, Navy General Hospital, Beijing, Beijing Hospital, Beijing Friendship Hospital, Peking University First Hospital, Peking University Third Hospital, China-Japan Friendship Hospital, Beijing Tsinghua Changgeng Hospital | Immune Thrombocytopenia | 06/24 | 06/25 | | |
NCT05852847: Low-dose Baricitinib Plus Danazol for Steroid-resistant/Relapse Immune Thrombocytopenia |
|
|
| Recruiting | 2 | 216 | RoW | Baricitinib 2 MG [Olumiant], Olumiant, Danazol | Peking University People's Hospital, Beijing Luhe Hospital, Chinese PLA General Hospital, Navy General Hospital, Beijing, Beijing Hospital, Beijing Friendship Hospital, Peking University First Hospital, Peking University Third Hospital, China-Japan Friendship Hospital, Beijing Tsinghua Changgeng Hospital | Immune Thrombocytopenia | 11/24 | 05/25 | | |
| Active, not recruiting | 2 | 532 | Europe, Japan, US, RoW | Enpatoran low dose, M5049, Enpatoran medium dose, Enpatoran high dose, Placebo | EMD Serono Research & Development Institute, Inc., Merck KGaA, Darmstadt, Germany | Systemic Lupus Erythematosus | 11/24 | 12/24 | | |
|
| Recruiting | 2 | 532 | Europe, Japan, US, RoW | M5049 low dose, Enpatoran, M5049 medium dose, M5049 high dose, Placebo, M5049 very high dose | Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany, Merck Healthcare KGaA | Systemic Lupus Erythematosus | 04/25 | 04/25 | | |
NCT05536505: Adjuvant Treatment Based on MRD for EGFR Mutant NSCLC |
|
|
| Recruiting | 2 | 180 | RoW | Adjuvant treatment for MRD positivity | Guangdong Association of Clinical Trials | MRD | 10/25 | 10/30 | | |
| Not yet recruiting | N/A | 150 | RoW | Guided cartilage regeneration membrane, Microfracture | Peking University Third Hospital, Zhongnan Hospital, Second Hospital of Shanxi Medical University, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, The First Affiliated Hospital of Kunming Medical College, Zunyi Medical College, The First Affiliated Hospital of Zhengzhou University, Chinese PLA General Hospital, Xi'an Honghui Hospital | Articular Cartilage Injury, Knee Ligament Injury | 08/22 | 08/23 | | |
| Recruiting | N/A | 2500 | RoW | | Xuanwu Hospital, Beijing, ChosenMed Technology (Beijing) Co.,Ltd | Non-small Cell Lung Cancer | 11/22 | 11/22 | | |
NCT06362291: Comparison of MRI AI-cTB Versus Routine cTB in Prostate Cancer Diagnosis: a Prospective Randomized Controlled Trial |
|
|
| Recruiting | N/A | 340 | RoW | MRI-AI guided cognitive prostate targeted biopsy, Routine cognitive prostate targeted biopsy | Peking University First Hospital | Prostate Cancer | 04/25 | 04/25 | | |
NCT06575361: Comprehensive Evaluation of MRI-AI in Prostate Cancer Diagnosis |
|
|
| Recruiting | N/A | 1000 | RoW | Combination of targeted biopsy and systematic biopsy | Peking University First Hospital | Prostate Cancer | 05/25 | 05/25 | | |
NCT06392737: Comparison of MRI Artificial Intelligence-guided cTB Versus Routine cTB in Prostate Cancer Diagnosis |
|
|
| Recruiting | N/A | 360 | RoW | MRI-AI guided cognitive prostate targeted biopsy, Routine cognitive prostate targeted biopsy | Peking University First Hospital | Prostate Cancer | 04/25 | 04/26 | | |
NCT06482658: Evaluation of Transrectal Perilesional Biopsy in Diagnosis of Prostate Cancer |
|
|
| Recruiting | N/A | 340 | RoW | Transrectal perilesional/regional systematic biopsy (PB/RSB), Combination of transrectal systematic biopsy and targeted biopsy | Peking University First Hospital | Prostate Cancer | 06/25 | 06/26 | | |
NCT06482645: Evaluation of Perilesional Biopsy in Diagnosis of Prostate Cancer |
|
|
| Recruiting | N/A | 300 | RoW | Perilesional/regional systematic biopsy, Combination of systematic biopsy and targeted biopsy | Peking University First Hospital, Beijing Hospital, Shanghai East Hospital | Prostate Cancer | 06/25 | 06/26 | | |
| Zhong, Hehe |
| Not yet recruiting | N/A | 150 | RoW | Guided cartilage regeneration membrane, Microfracture | Peking University Third Hospital, Zhongnan Hospital, Second Hospital of Shanxi Medical University, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, The First Affiliated Hospital of Kunming Medical College, Zunyi Medical College, The First Affiliated Hospital of Zhengzhou University, Chinese PLA General Hospital, Xi'an Honghui Hospital | Articular Cartilage Injury, Knee Ligament Injury | 08/22 | 08/23 | | |
| Cai, Shanjun |
NCT05439629: Efficacy Evaluation Study of BAT5906 and Lucentis® in Patients With Macular Degeneration |
|
|
| Active, not recruiting | 3 | 488 | RoW | BAT5906 injection, Lucentis | Bio-Thera Solutions | Neovascular (Wet) Age-related Macular Degeneration | 04/24 | 06/25 | | |
| Ren, Xu |
NCT05834387: The Impact of a Transitional Care Management Programme on the Migration Stress of Family Members of Patients |
|
|
| Recruiting | N/A | 30 | RoW | EICU Transfer Routine Care, Implementing interventions based on a 'health care-family-environment' linkage | Zunyi Medical College | Stress | 11/23 | 05/24 | | |
